While effective at controlling CNV formation in wet AMD, repetitive bolus dosing of anti-VEGF agents has been associated with accelerated retinal and choroidal degeneration and atrophy, leading to a progressive and significant decline in visual acuity8,36,37. Here, VEGFA is linked to optic choroid disorder.